Literature DB >> 9364992

An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.

D E Newby1, R A Wright, C A Ludlam, K A Fox, N A Boon, D J Webb.   

Abstract

The effects on blood flow and plasma fibrinolytic and coagulation parameters of intraarterial substance P, an endothelium dependent vasodilator, and sodium nitroprusside, a control endothelium independent vasodilator, were studied in the human forearm circulation. At subsystemic locally active doses, both substance P (2-8 pmol/min) and sodium nitroprusside (2-8 microg/min) caused dose-dependent vasodilatation (p <0.001 for both) without affecting plasma concentrations of PAI-1, von Willebrand factor antigen or factor VIII:C activity. Substance P caused local increases in t-PA antigen and activity (p <0.001) in the infused arm while sodium nitroprusside did not. At higher doses, substance P increased blood flow and t-PA concentrations in the noninfused arm. We conclude that brief, locally active and subsystemic infusions of intraarterial substance P cause a rapid and substantial local release of t-PA which appear to act via a flow and nitric oxide independent mechanism. This model should provide a useful and selective method of assessing the in vivo capacity of the forearm endothelium to release t-PA acutely.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364992

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  22 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.

Authors:  D E Newby; F N Witherow; R A Wright; P Bloomfield; C A Ludlam; N A Boon; K A A Fox; D J Webb
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

Review 3.  Atherosclerosis, cigarette smoking, and endogenous fibrinolysis: is there a direct link?

Authors:  Stanley Chia; David E Newby
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

4.  The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.

Authors:  Wilhelm Ridderstråle; Ott Saluveer; Maria Carlström; Sverker Jern; Thórdís J Hrafnkelsdóttir
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

5.  Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease.

Authors:  S D Robinson; C A Ludlam; N A Boon; D E Newby
Journal:  Heart       Date:  2005-04-29       Impact factor: 5.994

6.  Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.

Authors:  Ayaz M Rahman; Jonathan R Murrow; Muhiddin A Ozkor; Nino Kavtaradze; Ji Lin; Christine De Staercke; W Craig Hooper; Amita Manatunga; Salim Hayek; Arshed A Quyyumi
Journal:  J Vasc Res       Date:  2014-06-04       Impact factor: 1.934

7.  Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis.

Authors:  Hon-Wai Koon; Dezheng Zhao; Hua Xu; Collin Bowe; Alan Moss; Mary P Moyer; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

8.  Effects of losartan and delapril on the fibrinolytic system in patients with mild to moderate hypertension.

Authors:  Salvatore Paterna; Vincenzo Di Garbo; Gino Avellone; Pietro Di Pasquale; Antonina Cacia; Antonio Tuttolomondo; Giuseppe Follone; Antonietta Cardinale; Tiziana Maniscalchi; Giuseppe Licata
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 9.  Health behaviors and endothelial function.

Authors:  Jennifer L Gordon; Kim L Lavoie; André Arsenault; Blaine Ditto; Simon L Bacon
Journal:  J Behav Med       Date:  2007-09-29

10.  Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans.

Authors:  Derek T Smith; Greta L Hoetzer; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.